EUVIMEDEUVIMED entdecken
Open Access

Inferring fetal growth restriction as rare, severe, and stable over time

Allen J Wilcox, Olga Basso

European Journal of Epidemiology · 2023

DOI: 10.1007/s10654-023-00985-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Epidemiology, 2023. Verfasst von Allen J Wilcox und 1 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology Branch, National Institute of Environmental Health Sciences, PO Box 12233, Durham, NC, 27709, USA. wilcox@niehs.nih.gov. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Infant, Low Birth Weight. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reduced birthweight is a marker of pathologies that impair growth and also decrease survival. However, "fetal growth restriction" remains poorly defined. Assuming that birthweight itself has no causal effect on neonatal mortality, we can estimate the features of pathological fetal growth that would be required to produce the observed pattern of weight-specific mortality. Under the simplest possible scenario, we find that at 39-41 weeks, pathological fetal growth restriction affects only about 0.5% of U.S. births, with a neonatal mortality risk up to 220-fold. This surprising concentration of pathology among a tiny subset of babies would account for roughly half of neonatal deaths at term. Moreover, the prevalence of these pathological births appears to have remained relatively stable over recent decades, even as neonatal mortality in the U.S. has declined by 90%. In our model, the decline has been driven by the reduction in baseline mortality (i.e., mortality among babies unaffected by growth pathologies), while the relative risk of death among pathologically grown infants has apparently remained stable. Fetal growth restriction is conventionally regarded as common and preventable. In contrast, our observations suggest that pathological fetal growth is rare and constant over time, perhaps the result of unpreventable stochastic errors in embryonic development. Public health strategies may be more effective by setting aside attempts to increase birthweight, and focusing instead on the discovery and support of factors (unrelated to birthweight) that have produced the striking reductions in neonatal mortality over time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal Growth RetardationInfant, Low Birth WeightInfant, NewbornPregnancyInfantFemaleHumansBirth WeightGestational AgeFetal Development

Stichwörter der Autor:innen

BirthweightFetal growth restrictionNeonatal mortalitySmall for gestational age

Autor:innen und Institutionen

  • Epidemiology Branch, National Institute of Environmental Health Sciences, PO Box 12233, Durham, NC, 27709, USA. wilcox@niehs.nih.gov.
  • Centre for Fertility and Health Oslo, Oslo, Norway. wilcox@niehs.nih.gov.
  • Department of Obstetrics and Gynecology, McGill University, Montreal, QC, Canada.
  • Department of Epidemiology Biostatistics, and Occupational Health, McGill University, Montreal, QC, 27701, Canada.

Förderung

  • Intramural NIH HHS

Zitieren

APA

Wilcox, A. J., & Basso, O. (2023). Inferring fetal growth restriction as rare, severe, and stable over time. European Journal of Epidemiology. https://doi.org/10.1007/s10654-023-00985-7

Vancouver

Wilcox AJ, Basso O. Inferring fetal growth restriction as rare, severe, and stable over time. European Journal of Epidemiology. 2023. doi:10.1007/s10654-023-00985-7

BibTeX
@article{Wilcox2023,
  author = {Wilcox, Allen J and Basso, Olga},
  title = {Inferring fetal growth restriction as rare, severe, and stable over time},
  journal = {European Journal of Epidemiology},
  year = {2023},
  doi = {10.1007/s10654-023-00985-7}
}
Kostenlos starten →